Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?

Mohamed Attauabi; Jakob Seidelin; Johan Burisch; Danish COVID-IBD Study Group; Malte  Rosager Hansen; Pia Susanne Munkholm

doi:10.1136/gutjnl-2021-324397

Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?

Mohamed Attauabi, Jakob Seidelin, Johan Burisch, Danish COVID-IBD Study Group, Malte Rosager Hansen (Medlem af forfattergruppering), Pia Susanne Munkholm (Medlem af forfattergruppering)

13 Citationer (Scopus)

Originalsprog	Engelsk
Artikelnummer	gutjnl-2021-324397
Tidsskrift	Gut
Vol/bind	70
Udgave nummer	10
Sider (fra-til)	2020-2022
Antal sider	3
ISSN	0017-5749
DOI	https://doi.org/10.1136/gutjnl-2021-324397
Status	Udgivet - okt. 2021

Adgang til dokumentet

10.1136/gutjnl-2021-324397

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{89328d64e8d14edd8c0719da60360b65,

title = "Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?",

keywords = "5-aminosalicylic acid (5-ASA), COVID-19, crohn's disease, inflammatory bowel disease, ulcerative colitis",

author = "Mohamed Attauabi and Jakob Seidelin and Johan Burisch and {Danish COVID-IBD Study Group} and {Rosager Hansen}, Malte and Munkholm, {Pia Susanne}",

year = "2021",

month = oct,

doi = "10.1136/gutjnl-2021-324397",

language = "English",

volume = "70",

pages = "2020--2022",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "10",

}

TY - JOUR

T1 - Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19

T2 - an artefactual result of research methodology?

AU - Attauabi, Mohamed

AU - Seidelin, Jakob

AU - Burisch, Johan

AU - Danish COVID-IBD Study Group

A2 - Rosager Hansen, Malte

A2 - Munkholm, Pia Susanne

PY - 2021/10

Y1 - 2021/10

KW - 5-aminosalicylic acid (5-ASA)

KW - COVID-19

KW - crohn's disease

KW - inflammatory bowel disease

KW - ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=85101970874&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2021-324397

DO - 10.1136/gutjnl-2021-324397

M3 - Letter

C2 - 33658323

SN - 0017-5749

VL - 70

SP - 2020

EP - 2022

JO - Gut

JF - Gut

IS - 10

M1 - gutjnl-2021-324397

ER -